GPX4 and endometrial cancer: For example, the GPX4 inhibitor RSL3 effectively inhibits the proliferation of the medroxyprogesterone acetate (MPA)-resistant endometrial cancer cell line ECC-1 by enhancing oxidative stress and inducing ferroptosis, thereby reversing resistance (Murakami et al., 2023).